Literature DB >> 25926383

Emerging role of silent information regulator 1 (SIRT1) in hepatocellular carcinoma: a potential therapeutic target.

Yuting Wu1, Xiaoming Meng, Cheng Huang, Jun Li.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most prevalent neoplasms worldwide, ranking as the second leading cause of cancer-related death due to its high invasive and metastatic potential. SIRT1 (silent information regulator 1), a member of mammalian sirtuin family protein (SIRT1-SIRT7), functions as a conserved nicotinamide adenine dinucleotide (NAD)+-dependent deacetylase to implicate in the modulation of transcriptional silencing and cell survival. Recently, except for the regulatory role of SIRT1 in various biological processes, the carcinogenesis effect of SIRT1 was revealed in HCC. Importantly, SIRT1 was confirmed to be involved in tumorigenesis, metastasis, prognosis, and chemical resistant of HCC, as a result of its deacetylation of oncogenic or tumor suppressor factors. The focus of this review was to delineate the carcinogenesis effects of SIRT1 on HCC and present an overview of SIRT1 functions in normal liver followed by SIRT1 roles in HCC, with focus on the underlying molecular mechanism to promote SIRT1 as a new therapeutic target for HCC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25926383     DOI: 10.1007/s13277-015-3488-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  127 in total

1.  P53 is a tumor suppressor gene.

Authors:  Arnold J Levine; Cathy A Finlay; Philip W Hinds
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  Structural basis for sirtuin activity and inhibition.

Authors:  Hua Yuan; Ronen Marmorstein
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

3.  Hippo/YAP, β-catenin, and the cancer cell: a "ménage à trois" in hepatoblastoma.

Authors:  Karl G Sylvester; Sabine Colnot
Journal:  Gastroenterology       Date:  2014-07-27       Impact factor: 22.682

4.  SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis.

Authors:  V Byles; L Zhu; J D Lovaas; L K Chmilewski; J Wang; D V Faller; Y Dai
Journal:  Oncogene       Date:  2012-01-16       Impact factor: 9.867

5.  Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1.

Authors:  Masaya Tanno; Jun Sakamoto; Tetsuji Miura; Kazuaki Shimamoto; Yoshiyuki Horio
Journal:  J Biol Chem       Date:  2006-12-30       Impact factor: 5.157

6.  Mechanism of human SIRT1 activation by resveratrol.

Authors:  Margie T Borra; Brian C Smith; John M Denu
Journal:  J Biol Chem       Date:  2005-03-04       Impact factor: 5.157

7.  Annual report on status of cancer in China, 2010.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Ping Zhao; Hongmei Zeng; Xiaonong Zou; Jie He
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

8.  Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.

Authors:  Rui-Hong Wang; Kundan Sengupta; Cuiling Li; Hyun-Seok Kim; Liu Cao; Cuiying Xiao; Sangsoo Kim; Xiaoling Xu; Yin Zheng; Beverly Chilton; Rong Jia; Zhi-Ming Zheng; Ettore Appella; Xin Wei Wang; Thomas Ried; Chu-Xia Deng
Journal:  Cancer Cell       Date:  2008-10-07       Impact factor: 31.743

9.  Resveratrol alleviates alcoholic fatty liver in mice.

Authors:  Joanne M Ajmo; Xiaomei Liang; Christopher Q Rogers; Brandi Pennock; Min You
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-28       Impact factor: 4.052

10.  SIRT1 deacetylates and positively regulates the nuclear receptor LXR.

Authors:  Xiaoling Li; Songwen Zhang; Gil Blander; Jeanette G Tse; Monty Krieger; Leonard Guarente
Journal:  Mol Cell       Date:  2007-10-12       Impact factor: 17.970

View more
  14 in total

Review 1.  A Comprehensive Review: Molecular and Genetic Background of Indirect Inguinal Hernias.

Authors:  Salih Somuncu; Özge Sezin Somuncu
Journal:  Visc Med       Date:  2021-04-13

2.  MicroRNA-29c restores cisplatin sensitivity in liver cancer through direct inhibition of sirtuin 1 expression.

Authors:  Wei Zhang; Peng Luo
Journal:  Oncol Lett       Date:  2018-05-24       Impact factor: 2.967

3.  Silent information regulator T1 in aqueous humor of patients with cataract.

Authors:  Aki Kondo; Mari Goto; Tatsuya Mimura; Masao Matsubara
Journal:  Clin Ophthalmol       Date:  2016-02-15

4.  miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1.

Authors:  Chuntao Li; Zhixiong Liu; Kui Yang; Xin Chen; Yu Zeng; Jinfang Liu; Zhenyan Li; Yunsheng Liu
Journal:  Oncotarget       Date:  2016-06-14

5.  Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinoma.

Authors:  Hongyuan Jiang; Xiao Zhang; Yuquan Tao; Liang Shan; Qijun Jiang; Yongchun Yu; Feng Cai; Lifang Ma
Journal:  Oncotarget       Date:  2016-12-22

6.  Suppressive effect of microRNA-138 on the proliferation and invasion of osteosarcoma cells via targeting SIRT1.

Authors:  Zhenchao Yuan; Hao Mo; Ligen Mo; Juliang He; Zhenjie Wu; Xiang Lin
Journal:  Exp Ther Med       Date:  2017-05-04       Impact factor: 2.447

7.  MicroRNA-9 inhibits the proliferation and migration of malignant melanoma cells via targeting sirituin 1.

Authors:  Pingyuan Bu; Chengqun Luo; Quanyong He; Ping Yang; Xi Li; Dan Xu
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

Review 8.  Mito-Nuclear Communication in Hepatocellular Carcinoma Metabolic Rewiring.

Authors:  Tommaso Mello; Irene Simeone; Andrea Galli
Journal:  Cells       Date:  2019-05-05       Impact factor: 6.600

9.  RNA-binding protein RPS3 contributes to hepatocarcinogenesis by post-transcriptionally up-regulating SIRT1.

Authors:  Lijun Zhao; Jianzhong Cao; Kexin Hu; Penghui Wang; Guodong Li; Xiaodong He; Tanjun Tong; Limin Han
Journal:  Nucleic Acids Res       Date:  2019-02-28       Impact factor: 16.971

10.  SIRT1 increases YAP- and MKK3-dependent p38 phosphorylation in mouse liver and human hepatocellular carcinoma.

Authors:  Yulan Wang; Ran Cui; Xiao Zhang; Yongxia Qiao; Xiangfan Liu; Yefei Chang; Yongchun Yu; Fenyong Sun; Jiayi Wang
Journal:  Oncotarget       Date:  2016-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.